Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.

The research discusses evolving technologies used in creating more effective vaccines for horses against viral diseases such as Equine Viral Arteritis, West Nile Disease, and African Horse Sickness. The study focuses on the potential of these new generation vaccines and their critical role in the global horse industry.

Overview of Viral Diseases and Vaccines in Horses

• This research focuses on viral diseases that pose a significant threat to the horse industry across the globe due to the quick movement of large numbers of horses for competition and breeding. Such viral diseases include equine viral arteritis, West Nile disease, and African horse sickness.
• The paper discusses various types of vaccines used for the immunization of horses against these diseases, such as inactivated and live-attenuated (modified live virus, MLV) virus vaccines. Although these traditional vaccines remain popular and effective, the paper identifies certain deficiencies that necessitate the search for new vaccine technologies.

Development and Efficacy of New Generation Vaccines

• New generation vaccines are identified as a significant advance. These vaccines incorporate immunogenic proteins, feature mutations or deletions of critical genes, or use DNA vaccines.
• The researchers developed an alphavirus replicon-vectored equine arteritis virus (EAV) vaccine as a new generation option. Additionally, they evaluated a commercial canary pox virus-vectored vaccine for West Nile disease.
• The study found the new generation vaccines to be successful, thus paving the way for more development and research in this area, particularly for preventing other diseases like African horse sickness.

Implications and Future Directions

• The successful testing and development of these new generation vaccines highlight the potential for significant improvement in equine health management.
• This study indicates a shift towards these novel vaccine technologies, mainly due to their capability to overcome the deficiencies of current vaccine products.
• These advancements also indicate the potential for a positive impact on the global horse industry by providing more effective protection against viral diseases. This will be particularly relevant for emerging diseases of global significance such as African horse sickness.